Information Provided By:
Fly News Breaks for October 14, 2016
ICLR
Oct 14, 2016 | 06:46 EDT
Evercore ISI analyst Ross Muken upgraded ICON plc (ICLR) to Buy and raised its price target to $89 to reflect attractive relative valuation and unwarranted investor fears of a material step-down in earnings. The analyst has increased comfort Pfizer (PFE) is a manageable headwind to revenue growth and and bookings success in mid-tier accounts should result in total revenue growth.